CORE 2021 – On-demand
Published: 16 June 2021
-
Views:
71917
-
Likes:
7
Overview
Full programme
CORE 2021 - Day 1 Wrap-up
Overview
The 5th annual CORE meeting (16 and 17 June 2021) was hosted by Radcliffe Cardiology in collaboration with Optima Education and Abbott Vascular.
The meeting was led by Course Directors Prof Adrian Banning, Prof Evald Christiansen, Dr Jonathan Hill and Prof James Spratt and streamed from our London, Copenhagen, and Dublin hubs.
CORE 2021 focuses on contemporary standards of clinical practice, complex lesion and patient strategies and advanced diagnostic and treatment methods. The goal of CORE is to ensure procedural efficiencies while achieving durable patient outcomes, review patient care beyond intervention and discuss the best practices and innovation outside the catheterisation lab.
More from this programme
Part 1
CORE 2021 – Day 1: Morning – Physiology
Part 2
CORE 2021 – Day 1: Afternoon – Bifurcation Management
Part 3
CORE 2021 – Day 2: Morning – Durable Outcomes
Part 4
CORE 2021 – Day 2: Afternoon – Beyond Intervention
Faculty Biographies
James Spratt
Professor of Interventional Cardiology
James Spratt is a Professor of Interventional cardiology. A high-volume Interventional Cardiologist with an international reputation in complex PCI, with a sub-speciality interest in intravascular imaging and CTO. Widely published within this area and has performed live case demonstrations globally. He is interested in medical education and is the Founder of Optima Education.
Dr Spratt is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).
Adrian P Banning
Dr Adrian Banning is a consultant cardiologist specialising in percutaneous coronary intervention.
He is the president of the British Cardiac Intervention Society and was previously the Divisional Director for Cardiology, Cardiothoracic and Vascular Surgery at the John Radcliffe University Hospital, Oxford. Through his position at the John Radcliffe, and his own practice at Oxford’s The Manor Hospital, Prof Banning provides specialist regional services for coronary and valvular heart disease patients to an area of 1.2 million people.
Prof Banning is pioneering research in his field and lectures nationally and internationally. He has authored several books on coronary intervention and has more than 300 PubMed listed scientific papers to his name.